Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug ...

Modern agriculture is a data-rich but decision-constrained domain, where traditional methods struggle to keep pace with ...

The study introduces the concept of algorithmization to describe how organizations can be transformed into federated ...

Learn how AI drug discovery is revolutionising pharmaceutical research through collaboration with Eli Lilly and Schrödinger.

The 0→1 Doctrine, created by inventor Vatsal Soin, is a delete-before-share, quantum-resilient privacy framework that ...

Explore how Veerendra Nath transforms healthcare data systems with federated architectures, enhancing patient outcomes and ...

As organizations continue to move their systems to the cloud, they face a tough question: How do you keep an eye on ...

Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic ...

Collaboration makes AI models trained on over $1 billion in Lilly research data accessible directly in scientists' workflows.

For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

CARE-ACE supports autonomy through bounded agentic reasoning, in which diagnostic, prognostic, planning, and risk-assessment ...